Actelion announces change in its Board of Directors

05-Jan-2011 - Switzerland

Actelion Ltd announced that Dr. Elias Zerhouni has resigned from Actelion's Board of Director at the end of 2010. Dr. Zerhouni will focus on his new role as President, Global Research and Development at Sanofi-aventis, an executive function he is assuming as of the beginning of 2011.

Robert Cawthorn, Chairman of the Board of Directors at Actelion, commented:"We would like to thank Dr. Zerhouni for his valuable contribution as a Board member. We have benefited from his vast scientific managerial and strategic experience. We wish him success in his new executive role that leads to him leaving our Board."

Other news from the department people

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?